High unbound plasma concentration of M-2, an active metabolite, is associated with shorter survival in patients with metastatic colorectal cancer who received regorafenib
High unbound plasma concentration of M-2, an active metabolite, is associated with shorter survival in patients with metastatic colorectal cancer who received regorafenib
复制标题
M-2（一种活性代谢物）的未结合血浆浓度较高，与接受瑞戈非尼治疗的转移性结直肠癌患者的生存期较短有关
DOI：
--
复制
发表时间：
2019
期刊：
影响因子：
--
通讯作者：
Yasutsuna Sasaki
中科院分区：
文献类型：
--
作者：
Yutaro Kubota;Ken-ichi Fujita;Takehiro Takahashi;Yu Sunakawa;Hiroo Ishida;Kazuyuki Hamada;Wataru Ichikawa;Takuya Tsunoda;Yusuke Masuo;Yukio Kato;Yasutsuna Sasaki
